Drug & supplement interaction

Shark Cartilage + Lorlatinib

Lorlatinib brand name: Lorbrena.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Shark Cartilage and Lorlatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Shark Cartilage and Lorlatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lorlatinib and Shark Cartilage in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Shark Cartilage safety at a glance

Shark Cartilage overall Use caution Often poorly studied, may cause digestive upset, and proven benefits are lacking.
Pregnancy Avoid Not enough safety data; avoid during pregnancy.
Breastfeeding Avoid Not enough safety data; avoid while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lorlatinib and Shark Cartilage? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Lorlatinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Lorlatinib is filed under 3 classifications — cytochrome p450 3a4 (cyp3a4) inducers, cytochrome p450 3a4 (cyp3a4) substrates, oral drugs. Shark Cartilage has documented interactions with 1 drug class — the most serious being immunosuppressants (moderate) — and none of Lorlatinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Shark Cartilage Does Interact With Other Medications

Shark Cartilage has 121 moderate known drug interactions in our database — Lorlatinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Shark Cartilage

Covers the 2,830 medications we’ve checked against Shark Cartilage. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Shark Cartilage and Lorlatinib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. 2 of them are worth acting on rather than waiting out — marked below.

  • High blood sugar Worth acting on Additional detail

    Shark Cartilage

    “Orally, shark cartilage can cause hyperglycemia, hypoglycemia, and hypercalcemia.”

    Shark Cartilage · Natural Medicines adverse-effect record, reported in hypercalcemia.

    5 sources cited
    1. 2014. Lane IW, Comac L. Sharks don't get cancer. Garden City, NY: Avery Publishing Group; 1992.
    2. 2015. Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55. PubMed
    3. 6716. Leitner SP, Rothkopf MM, Haverstick L, et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients (pts) with either metastatic breast or prostate cancer refractory to standard treatment. Proc Am Soc Clinical Oncol 1998;17:A240.
    4. 10900. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13:1259-63..
    5. 74724. Leitner SP, Rothkopf MM, Haverstick DD, and et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients with either metastatic breast or prostate cancer refractory to standard treatment. Amer Soc Clin Oncol 1998;17:A240.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

  • Liver problems Worth acting on Additional detail

    Shark Cartilage

    “Orally, shark cartilage can cause acute hepatitis, with symptoms including low-grade fever, jaundice, yellowing of the eyes, right upper quadrant tenderness, and elevated liver enzymes.”

    Shark Cartilage · Natural Medicines adverse-effect record, reported in hepatitis.

    1 source cited
    1. 2012. Ashar B, Vargo E. Shark cartilage-induced hepatitis [letter]. Ann Intern Med 1996;125:780-1. PubMed

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

  • Swelling reported in 3.9% of FDA reports for Lorlatinib Additional detail

    Shark Cartilage

    “Orally, shark cartilage can cause hypotension and peripheral edema.”

    Shark Cartilage · Natural Medicines adverse-effect record, reported in hypotension.

    4 sources cited
    1. 2014. Lane IW, Comac L. Sharks don't get cancer. Garden City, NY: Avery Publishing Group; 1992.
    2. 2015. Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55. PubMed
    3. 6716. Leitner SP, Rothkopf MM, Haverstick L, et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients (pts) with either metastatic breast or prostate cancer refractory to standard treatment. Proc Am Soc Clinical Oncol 1998;17:A240.
    4. 10900. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13:1259-63..

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • Fever Additional detail

    Shark Cartilage

    Recorded for Shark Cartilage in the same Natural Medicines adverse-effect record shown under Liver problems above.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

  • Constipation / Vomiting / Nausea Additional detail

    Shark Cartilage

    “Orally, shark cartilage can cause taste disturbances, nausea, vomiting, dyspepsia, constipation, cramping, and bloating.”

    Shark Cartilage · Natural Medicines adverse-effect record, reported in constipation.

    6 sources cited
    1. 2014. Lane IW, Comac L. Sharks don't get cancer. Garden City, NY: Avery Publishing Group; 1992.
    2. 2015. Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55. PubMed
    3. 6716. Leitner SP, Rothkopf MM, Haverstick L, et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients (pts) with either metastatic breast or prostate cancer refractory to standard treatment. Proc Am Soc Clinical Oncol 1998;17:A240.
    4. 10900. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13:1259-63..
    5. 74724. Leitner SP, Rothkopf MM, Haverstick DD, and et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients with either metastatic breast or prostate cancer refractory to standard treatment. Amer Soc Clin Oncol 1998;17:A240.
    6. 74730. Rosenbluth, RJ, Jennis, AA, Cantwell, S, and et al. Oral shark cartilage in the treatment of patients with advanced primary brain tumors. A phase II pilot study (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 1999;18:A554.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

  • Tiredness / Dizziness Additional detail

    Shark Cartilage

    “Orally, shark cartilage can cause dizziness, altered consciousness, decreased sensation, and fatigue.”

    Shark Cartilage · Natural Medicines adverse-effect record, reported in fatigue.

    5 sources cited
    1. 2014. Lane IW, Comac L. Sharks don't get cancer. Garden City, NY: Avery Publishing Group; 1992.
    2. 2015. Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55. PubMed
    3. 6716. Leitner SP, Rothkopf MM, Haverstick L, et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients (pts) with either metastatic breast or prostate cancer refractory to standard treatment. Proc Am Soc Clinical Oncol 1998;17:A240.
    4. 10900. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13:1259-63..
    5. 74725. Milner M. A guide to the use of shark cartilage in the treatment of arthritis and other inflammatory joint diseases. Amer Chiropractor 1999;21:40-42.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed ›

Reported for Shark Cartilage but not commonly for Lorlatinib: a change in taste, low blood sugar, low blood pressure and stomach upset.

Effects for Lorlatinib come from the ADVERSE REACTIONS section of its FDA label; effects for Shark Cartilage come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 6,977 voluntary FDA FAERS reports for Lorlatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Overlapping uses

What Lorlatinib Is Prescribed For, and What Shark Cartilage Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Lorlatinib is a prescription medicine with approved uses on its FDA label. Shark Cartilage is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Lorlatinib is prescribed for: Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment. Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Shark Cartilage has been studied for:

  • Cancer studied, not established Shark Cartilage has been studied for this. Natural Medicines rates the evidence: Likely Ineffective Read what the research shows

    Shark Cartilage for cancer

    Most clinical research shows that oral shark cartilage is not beneficial in people with advanced cancer.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Lorlatinib on your own; if you are taking Shark Cartilage for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Lorlatinib

This page covers Shark Cartilage only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lorlatinib page lists 153 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 110 moderate · 40 minor.

From our pharmacist’s overview on the Lorlatinib page

“Lorlatinib (Lorbrena) treats ALK-positive lung cancer, and keeping its blood level steady is central to keeping the cancer controlled, so I treat this list with genuine vigilance. Nearly all 153 interactions on file run through CYP3A4, the enzyme that clears the drug.”

Reviewed by 2 · Jul 18, 2026

Open the Lorlatinib interaction page

One more smart check

Taking Shark Cartilage as Part of a Dietary Supplement Product? Check It for Interactions

We hold 2 real supplement products containing Shark Cartilage, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Shark Cartilage. Even though Shark Cartilage itself has no known interaction with Lorlatinib, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Shark Cartilage and Lorlatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Shark Cartilage
Steady interest

#1,202 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lorlatinib
Top half

#1,372 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Shark Cartilage reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Shark Cartilage and Lorlatinib records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Shark Cartilage

What is Shark Cartilage?

  • Cancer support (popular use)
  • Arthritis and joint pain
  • Psoriasis
  • Wound healing
  • General immune support

Shark cartilage is a supplement made from the skeletal tissue of sharks that was heavily promoted for cancer and joint conditions, but good-quality clinical trials have not shown meaningful benefit. It is generally not recommended, and there are real environmental and safety concerns, so talk with your doctor or pharmacist before considering it.

Cartilage (skeletal tissue) from sharks, often from species such as the spiny dogfish and hammerhead · Capsules, tablets, powder

An interaction check asks whether these two react with each other — it does not ask whether Shark Cartilage is a good idea for someone in your situation. Here is what our Shark Cartilage record says about it on its own.

Shark Cartilage: dosing

There is no established or standardized dose for shark cartilage, and products vary widely in their content and quality. Studies have used very different amounts and forms, so no reliable recommended dose exists.If you are considering shark cartilage despite the limited evidence, follow the directions on the product label and do not exceed them.

From our Shark Cartilage monograph — the full record covers uses, side effects and every documented interaction.

Read the full Shark Cartilage monograph & all interactions
Medication

About Lorlatinib

What Is Lorlatinib Used For?

Brand name: Lorbrena

Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment.

Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Most-Reported Side Effects for Lorlatinib

From FAERS, the FDA’s public side-effect reporting system (6,977 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Neoplasm progression 621 reports
Hallucination 404 reports
Weight increased 399 reports
Blood cholesterol increased 348 reports
Dyspnea 270 reports
See full Lorlatinib drug information
Keep checking

Other Drugs & Shark Cartilage

Browse every other medication we’ve checked against Shark Cartilage — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
121Moderate
0Minor
2,708No known interaction
Moderate

121 interactions

Showing 60 of 121 moderate interactions — see all 121 on the Shark Cartilage page.

No interaction 2,708 drugs checked — show the list
Evidence & sources

Shark Cartilage References

The 12 references that drive our Shark Cartilage monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Ashar B, Vargo E. Shark cartilage-induced hepatitis [letter]. Ann Intern Med 1996;125:780-1. PubMed
  2. Lane IW, Comac L. Sharks don't get cancer. Garden City, NY: Avery Publishing Group; 1992.
  3. Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55. PubMed
  4. Leitner SP, Rothkopf MM, Haverstick L, et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients (pts) with either metastatic breast or prostate cancer refractory to standard treatment. Proc Am Soc Clinical Oncol 1998;17:A240.
  5. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13:1259-63..
  6. Merly, L., Simjee, S., and Smith, S. L. Induction of inflammatory cytokines by cartilage extracts. Int Immunopharmacol. 2007;7(3):383-391. PubMed
  7. Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., and Safari, E. Effect of shark cartilage derived protein on the NK cells activity. Immunopharmacol.Immunotoxicol. 2011;33(3):403-409. PubMed
  8. Leitner SP, Rothkopf MM, Haverstick DD, and et al. Two phase II studies of oral dry shark cartilage powder (SCP) in patients with either metastatic breast or prostate cancer refractory to standard treatment. Amer Soc Clin Oncol 1998;17:A240.
  9. Milner M. A guide to the use of shark cartilage in the treatment of arthritis and other inflammatory joint diseases. Amer Chiropractor 1999;21:40-42.
  10. Rosenbluth, RJ, Jennis, AA, Cantwell, S, and et al. Oral shark cartilage in the treatment of patients with advanced primary brain tumors. A phase II pilot study (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 1999;18:A554.
  11. Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, and Dupont E. Phase I/II trial on AE-941 (Neovastat) in patients with metastatic refractory prostate cancer (abstract presentation). Canadian Urological Association Annual Meeting (June 24-27, 2001).
  12. Merly L, Smith SL. Pro-inflammatory properties of shark cartilage supplement. Immunopharmacol Immunotoxicol. 2015;37(2):140-7. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Shark Cartilage and Lorlatinib Together: Common Questions

Is it safe to take Shark Cartilage with Lorlatinib?
We do not list a known interaction between Shark Cartilage and Lorlatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Shark Cartilage and Lorlatinib have any of the same side effects?
Yes — our sources link each of them separately to 9 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Shark Cartilage and Lorlatinib used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Shark Cartilage in each. That is a conversation for your prescriber, especially if Lorlatinib is being adjusted to a target.
How was the Shark Cartilage and Lorlatinib combination checked?
Interactions in our licensed database are recorded against drug classes. Lorlatinib is filed under 3 classifications, and Shark Cartilage has documented interactions with 1 drug class — none of Lorlatinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Shark Cartilage interact with any other medications?
Yes. Shark Cartilage has 121 documented drug interactions in our database — Lorlatinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Lorlatinib interact with any supplements?
Yes. Lorlatinib has documented interactions with 153 supplements in our database — Shark Cartilage is not one of them. The Lorlatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Lorlatinib and Shark Cartilage?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.